Hikma Pharmaceuticals USA INC. recalls

3 recalls.

• Abirtega recall (Hikma Pharmaceuticals USA INC.)
  DrugClass IIReported October 28, 2026 · Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.
• Ramipril Capsules USP recall (Hikma Pharmaceuticals USA INC.)
  DrugClass IIReported September 2, 2026 · Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU).
• Alendronate Sodium Oral Solution recall (Hikma Pharmaceuticals USA INC)
  DrugClass IIReported May 6, 2026 · This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.